Physician team grows to 11 at nationally and internationally-recognized Chicagoland fertility center with 35,000 babies born

CHICAGO, May 23, 2018 (GLOBE NEWSWIRE) — Dr. Asima K. Ahmad has joined the nationally and internationally-recognized physician team at Fertility Centers of Illinois. The 11-physician team at Fertility Centers of Illinois has eight offices located throughout Chicagoland and serves patients throughout the Midwest and across the globe.

Dr. Ahmad is board certified in Obstetrics and Gynecology and completed a fellowship in Reproductive Endocrinology and Infertility at the University of California in San Francisco. Dr. Ahmad received her medical degree from the Pritzker School of Medicine at the University of Chicago and completed her residency at the Yale School of Medicine. She also received her Masters in Public Health at Harvard University.

A native of Chicago who grew up on the south side of the city, Dr. Ahmad is excited to treat patients in the city she called home as a child. She is passionate about the latest research and innovations that can benefit patients on their treatment journey and has completed extensive work, including research domestically and abroad as well as co-founding a startup fertility company designed to increase access to fertility care. The progressive reproductive laws in Illinois, some of the most liberal in the country, also allow her to offer a wide breadth of care to patients. In addition to English, Dr. Ahmad is fluent in Punjabi, Urdu, Hindi, and can speak basic Spanish, allowing her to remove barriers to treatment for many local communities.

“No two patients are alike, but they are all united in the goal to become parents,” says Dr. Ahmad. “I believe that achieving one’s highest fertility potential and having a family is a basic human right, and I am excited to join the esteemed Fertility Centers of Illinois physician team and help people access that care.”

Dr. Ahmad treats patients at the Warrenville and Tinley Park offices and is also receiving a warm welcome from the Fertility Centers of Illinois family.

“We are proud to have Dr. Ahmad joining our physician group,” explains Dr. Christopher Sipe, President of Fertility Centers of Illinois. “She is a skilled physician who is fluent in several languages and passionate about helping women and men feel empowered through the treatment process.”

For more than 30 years, Fertility Centers of Illinois has helped thousands of couples begin their families with more than 35,000 babies born. Fertility Centers of Illinois has earned a reputation for early to the market for state of the art technology and currently serves as the premier and largest fertility center in the Midwest region.

Fertility Centers of Illinois (FCI) is one of the leading fertility treatment practices in the United States, providing advanced reproductive endocrinology services for over 30 years with more than 35,000 babies born. FCI physicians, embryologists and support staff are stringently chosen based on educational background, medical skills and their ability to collaborate. With a team of 11 nationally and internationally recognized physicians who treat thousands of patients each year, the practice has earned a reputation for early to the market with state of the art technology. FCI is dedicated to medical and clinical excellence and continues to invest in the latest technologies and research. FCI offers a comprehensive range of fertility treatments with an emphasis on in vitro fertilization and its related applications and technologies. The practice has one of the largest Collaborative Reproduction Centers, providing treatment options for Egg Donation and Gestational Carriers. The practice has extensive experience in the continually evolving field of genetic screening of embryos, including diagnosis for single gene abnormalities. FCI has expanded their experience and technologies into the rapidly growing realm of egg freezing with a personalized paradigm of treatment for each patient throughout reproductive life. As the premier and largest fertility practice in the Midwest region, Fertility Centers of Illinois has eight physician offices serving patients in the Chicagoland region, northern Indiana, and southern Wisconsin. Learn more by calling 877-324-4483 or visiting

Media Contact:
Gina Cannon


You May Also Like


胸部恶性肿瘤界的全球领袖开展调查,以评估如何改善全球分子诊断丹佛, July 13, 2018 (GLOBE NEWSWIRE) -- 国际肺癌研究协会(IASLC)鼓励所有参与肺癌患者分子诊断的人员参加一项全球调查,本调查旨在评估最佳实务的实施情况及最终制定分子诊断的全球指南。欲参加IASLC肺癌分子诊断全球调查,请访问。 IASLC的医学博士、哲学博士和首席执行官Fred R. Hirsch表示,“肺癌科学的发展速度非常快。”Hirsch博士也指出,“为了确保患者护理跟上科学的发展,我们需要了解实施及采用新疗法的障碍。在收集、利用和传播数据以改变患者治疗效果方面,IASLC拥有独特的优势。” 许多指南建议在拥有腺癌组织学成分的晚期非小细胞肺癌(NSCLC)中测试致瘤分子驱动因子,例如EGFR、ROS1、ALK和BRAF。针对这些特定致癌分子驱动因子的疗法可以使患者延年益寿,但是在开始治疗之前需要知道是否存在驱动因子。 为了解肺癌分子诊断的现状以及任何区域性挑战和实施障碍,包括为什么并非所有地区均参与分子诊断,专家参与本调查至关重要。IASLC邀请医疗保健专业人员和其他利益相关方参与本调查。本调查提供英语、中文、日语、葡萄牙语和西班牙语版本。 肺癌分子诊断的IASLC全球调查结果将1)确定分子诊断的现状,2)揭露任何区域实施挑战或障碍,及3)为制定未来策略提供相关信息,以克服向全球肺癌患者普及分子诊断的障碍。主要发现摘要将与受访者分享,并且完整报告将会提交至IASLC官方期刊Journal ...